Ignite Creation Date:
2024-05-05 @ 5:26 PM
Last Modification Date:
2024-10-26 @ 9:32 AM
Study NCT ID:
NCT00458042
Status:
TERMINATED
Last Update Posted:
2007-11-12
First Post:
2007-04-05
Brief Title:
Transitioning To IV Remodulin From Ventavis in Patients With PAH Safety Efficacy and Treatment Satisfaction
Sponsor:
United Therapeutics
Organization:
United Therapeutics
Organization Data
Organization:
United Therapeutics
Class:
INDUSTRY
Study ID:
RIV-PH-412
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
United Therapeutics
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None